Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KINNATE BIOPHARMA INC.

(KNTE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 1 724530530-
Enterprise Value (EV)1 1 358298297436
P/E ratio -7,53x-6,05x-5,03x-4,50x
Yield ----
Capitalization / Revenue ----
EV / Revenue ----
EV / EBITDA -37,8x-3,38x-2,83x-3,77x
Price to Book ----
Nbr of stocks (in thousands) 43 32743 69643 696-
Reference price (USD) 39,812,412,412,4
Announcement Date 03/29/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 -----
EBITDA1 --35,9-88,1-105-116
Operating profit (EBIT)1 --36,0-89,8-118-150
Operating Margin -----
Pre-Tax Profit (EBT)1 --35,8-89,3-115-145
Net income1 -9,94-35,8-89,3-115-145
Net margin -----
EPS2 -2,72-5,28-2,05-2,47-2,76
Dividend per Share2 -----
Announcement Date 09/04/202003/29/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ------
EBITDA --21,0----
Operating profit (EBIT)1 -17,5-21,6-24,8-26,0-26,9-28,5
Operating Margin ------
Pre-Tax Profit (EBT)1 -17,5-21,4-24,7-25,7-27,4-28,9
Net income1 -17,5-21,4-24,7-25,7-27,4-28,9
Net margin ------
EPS2 -0,40-0,49-0,57-0,59-0,58-0,61
Dividend per Share ------
Announcement Date 05/17/202108/16/202111/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 -36523223393,7
Leverage (Debt / EBITDA) -10,2x2,63x2,22x0,81x
Free Cash Flow1 --30,5-73,5-89,5-113
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex1 -0,300,202,553,55
Capex / Sales -----
Announcement Date 09/04/202003/29/2021---
1 USD in Million
Key data
Capitalization (USD) 529 596 671
Number of employees 61
Free-Float 85,0%
Free-Float capitalization (USD) 450 075 545
Avg. Exchange 20 sessions (USD) 1 589 403
Average Daily Capital Traded 0,30%
EPS & Dividend